Finding Brixadi in Maryland isn’t as straightforward as it should be. Providers who carry it are specific, insurance verification takes preparation, and asking for “buprenorphine” at the wrong clinic often lands you with a prescription for daily pills instead of the injection you wanted. This guide walks through exactly what Brixadi is, who qualifies, where to get it across Maryland, and how to avoid the detours that slow most people down.
What Brixadi Actually Is and Why It Matters for OUD Treatment
According to the Maryland Department of Health, opioid use disorder affected more than 120,000 Maryland residents in a recent reporting period, yet fewer than 30% received any form of medication-assisted treatment. Brixadi (buprenorphine extended-release injectable) is an FDA-approved treatment for opioid use disorder that addresses one of the most consistent reasons treatment fails: daily dosing.
With oral buprenorphine, you take a film or tablet every day. Miss a dose during a stressful week and the stability you’ve built starts to slip. Brixadi removes that variable entirely. A provider administers the injection in office, either weekly or monthly, and your treatment coverage holds between appointments without any action required on your part.
That flexibility in schedule is one of the things that makes Brixadi worth understanding in detail. The weekly option suits patients who are earlier in treatment and benefit from more frequent contact with their care team. The monthly option fits patients who have stabilized and want fewer clinic visits. The dose format matches where you are in recovery, not just a fixed protocol.
How Brixadi Differs from Other Buprenorphine Options
A 2023 FDA review of extended-release buprenorphine formulations confirmed that Brixadi and Sublocade are both subcutaneous injections (shots under the skin, not into the muscle) delivering buprenorphine without daily dosing. The difference between them comes down to scheduling and dose structure.
Sublocade is available only as a once-monthly injection. Brixadi offers both weekly and monthly dosing, which gives prescribers the option to start with more frequent administration and transition patients to monthly as they stabilize. For someone just starting injectable treatment, that graduated path can matter. For someone already stable who wants maximum simplicity, understanding how these injectable formats compare helps clarify which conversation to have with your provider. One concrete step: use this distinction when calling a clinic, and ask specifically whether they offer the weekly Brixadi dose or only the monthly option.
Who Qualifies for Brixadi in Maryland
A 2022 SAMHSA clinical guidance update confirmed that patients transitioning to extended-release injectable buprenorphine should first demonstrate tolerability on an oral buprenorphine formulation. That typically means a short period on sublingual buprenorphine to confirm the medication works for you before receiving the injection. Beyond that, standard contraindications apply, including certain respiratory conditions and sensitivity to buprenorphine.
The populations served across Maryland locations include Medicaid recipients, patients on commercial insurance, and individuals without coverage. Maryland Medicaid covers Brixadi, though prior authorization is sometimes required depending on the plan. Before your first call to a provider, identify which category applies to you. That one piece of preparation makes the intake conversation faster and avoids back-and-forth on coverage that can otherwise delay your first appointment.
Co-occurring mental health conditions, including depression, anxiety, and trauma-related disorders, do not disqualify you. Integrated behavioral health support is part of how treatment is structured at MD M.A.T.T. locations.
Where to Get Brixadi in Maryland
According to SAMHSA’s 2023 behavioral health treatment locator data, Maryland has a significant treatment gap in injectable buprenorphine access. Providers who carry Brixadi specifically, and who administer it in office, are not evenly distributed across the state.
Because Brixadi is a controlled substance that requires in-office administration by a certified provider, you cannot fill it at a pharmacy and self-administer. That narrows the field considerably. MD M.A.T.T. offers Brixadi at locations in Baltimore, College Park, Linthicum Heights, Nottingham, and Owings Mills, covering most of the state’s population centers. If you are searching for Brixadi injection sites across Maryland, those five locations represent accessible, Medicaid-accepting options without requiring a referral.
When you call, ask specifically for Brixadi by name. Asking for “buprenorphine” often routes the conversation toward oral Suboxone, which is a different format. Naming the medication directly signals to the scheduling team that you know what you’re looking for and moves the conversation to availability faster.
What to Expect at Your First Appointment
A 2021 study published in the Journal of Substance Abuse Treatment found that same-day or next-day access to buprenorphine significantly increased 30-day treatment retention compared to appointments scheduled more than 72 hours out. Getting in quickly matters, and knowing what happens at the first visit reduces friction.
The first appointment includes intake paperwork, insurance or Medicaid verification, a brief clinical assessment to confirm eligibility, and the injection itself if you are already stable on oral buprenorphine. If you are starting fresh, the provider will outline the transition protocol. Knowing what questions to ask a prospective Brixadi provider before that first visit helps you walk in prepared rather than reactive.
Bring your insurance card and a current medication list. Those two items cut intake time and prevent the most common administrative delays at the first visit.
Getting Brixadi Without Insurance or With Medicaid
The 2023 Maryland BSAS annual report estimated that approximately 35% of individuals seeking OUD treatment in Maryland are uninsured or covered by Medicaid. Both groups have viable paths to Brixadi.
Maryland Medicaid covers Brixadi. Prior authorization is sometimes required, meaning the provider submits documentation to your plan confirming medical necessity before the first injection is approved. This process is handled by the billing team, not you, but knowing it exists means you will not be caught off guard if there is a short delay between your clinical assessment and your first injection. Ask the billing team at your chosen location whether prior authorization is needed for your specific plan before the appointment date. That one question eliminates the most common coverage surprise.
For patients without insurance, patient assistance programs through the manufacturer are available. The scheduling team can confirm current eligibility and guide you through the application.
Common Reasons People Get Stuck and How to Avoid Them
A 2022 study in Health Affairs analyzing OUD treatment access across mid-Atlantic states identified three primary barriers: lack of provider-specific information, referral loops that delay direct access, and insurance verification delays that discourage follow-through. Each one has a straightforward fix.
The first barrier is not knowing which providers specifically carry Brixadi. Searching for general buprenorphine providers and then discovering they only offer oral formulations wastes time and erodes motivation. Going directly to a clinic that fits your geographic and insurance situation short-circuits that loop.
The second barrier is being routed to oral buprenorphine when you prefer the injectable format. This happens when the intake question is too broad. Asking “Do you administer Brixadi on-site?” instead of “Do you offer buprenorphine?” gets a direct answer and avoids the redirect.
The third barrier is insurance verification delays. Prior authorization for injectable buprenorphine can take a few days if not initiated early. Calling ahead and asking the billing team to start that process before your appointment date means coverage is confirmed before you arrive, not after.
What to Try This Week
Call the Maryland location nearest to you, name Brixadi specifically, and ask about same-week availability. Medicaid is accepted, no referral is required, and the first appointment is designed to move efficiently when you come in prepared.
The process at these locations is built to remove barriers. Starting is still the hardest step, but it is one phone call. Make that call this week, ask for Brixadi by name, and let the intake team handle the rest.